INTERNATIONAL PATENT: SHANGHAI AILUX BIOTECHNOLOGY CO., LTD., 上海艾乐晞生物科技有限公司 FILES APPLICATION FOR "ANTI-HUMAN FGFR2B ANTIBODY AND USE THEREOF"

GENEVA, April 27 -- SHANGHAI AILUX BIOTECHNOLOGY CO., LTD. (Room 303, Building 1, No. 207 Huanqiao RoadPudong New Area, Shanghai 201315), 上海艾乐晞生物科技有限公司 (中国上海市浦东新区环桥路207号1幢303室) filed a patent application (PCT/CN2025/127265) for "ANTI-HUMAN FGFR2B ANTIBODY AND USE THEREOF" on Oct 13, 2025. With publication no. WO/2026/081985, the details related to the patent application was published on Apr 23, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual ...